SCHEMBL13594635

SCHEMBL13594635

O=Nc1ccc(O)cc1N=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.40
ALDH1A1 P00352 8/20 0.38
MAPT P10636 7/20 0.38
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
HSD17B10 Q99714 4/20 0.38
LMNA P02545 4/20 0.38
POLB P06746 3/20 0.38
HPGD P15428 2/20 0.38
ALOX15 P16050 2/20 0.38
NFKB1 P19838 2/20 0.38
THPO P40225 2/20 0.38
MTOR P42345 2/20 0.38
RECQL P46063 2/20 0.38
BLM P54132 2/20 0.38
PMP22 Q01453 2/20 0.38
HIF1A Q16665 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
RGS12 O14924 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3070179 0.82 ALDH1A1 (0.45) EGFRALDH1A1MAPTMEN1KMT2A
SCHEMBL532655 0.82 EGFR (0.54) EGFRALDH1A1MAPTMEN1KMT2A
SCHEMBL11213358 0.78 CA14 (0.46) EGFRALDH1A1MAPTMEN1KMT2A
Methyl Alcohol SCHEMBL27630444 0.78 EGFR (0.50) EGFRALDH1A1MAPTMEN1KMT2A
SCHEMBL22134656 0.78 MEN1 (0.42) EGFRALDH1A1MAPTMEN1KMT2A
SCHEMBL10058199 0.78 ESR1 (0.41) EGFRALDH1A1MAPTMEN1KMT2A
SCHEMBL766049 0.78 LMNA (0.44) EGFRALDH1A1MAPTMEN1KMT2A
SCHEMBL9077264 0.78 HSD17B10 (0.52) EGFRMEN1KMT2AHSD17B10LMNA
SCHEMBL12758924 0.78 HSD17B10 (0.52) ALDH1A1MEN1KMT2AHSD17B10TDP1
SCHEMBL12657263 0.78 ACHE (0.43) ALDH1A1MAPTMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7635774-B2 2-Amino-imidazole derivatives; modulate the expression and/or function of proteins involved in inflammation, immune response regulation and cell proliferation AMGEN INC. (US) 2009-12-22 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 EGFR 4221/4885ALDH1A1 1789/4885MAPT 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.